Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alaris Medical Systems, now a primary brand under Becton Dickinson (BD), is a global leader in medication safety and infusion therapy. The company is best known for the Alaris System, a modular point-of-care platform that integrates large-volume infusion, syringe delivery, and patient monitoring into a single interface. A key innovation is the Guardrails Suite MX software, which pioneered 'smart pump' technology by providing clinical decision support and dose error reduction systems. These technologies are designed to improve patient safety by preventing medication errors during intravenous administration. Alaris products are foundational components in hospital medication management workflows worldwide, particularly in critical care and oncology settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alaris Medical Systems.